Apuli Maricel, Chief Accounting Officer of BridgeBio Pharma ($BBIO), made five open market sales of company stock over the past year, totaling about $403,000. Her most recent sale occurred on February 26, 2026. These transactions rank 6,926th among 11,678 insiders by sale value, well below the average of 8.6 million per insider and 6.37 sales. Maricel reported no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | A | Common Stock | 14170 | $0.00 | 136,115.0000 | 192,708,813 | 11.62% | 0.01% |
| Feb. 26, 2026 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | S | Common Stock | 2000 | $66.00 | 121,945.0000 | 192,708,813 | 1.61% | 0.00% |
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | S | Common Stock | 510 | $74.31 | 123,945.0000 | 192,708,813 | 0.41% | 0.00% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | F | Common Stock | 4349 | $75.25 | 124,455.0000 | 192,708,813 | 3.38% | 0.00% |
| Dec. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | F | Common Stock | 2003 | $75.15 | 128,294.0000 | 192,708,813 | 1.54% | 0.00% |
| Dec. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | S | Common Stock | 2000 | $74.26 | 130,297.0000 | 192,708,813 | 1.51% | 0.00% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | F | Common Stock | 4781 | $66.39 | 132,297.0000 | 192,708,813 | 3.49% | 0.00% |
| Aug. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | F | Common Stock | 4781 | $51.32 | 137,078.0000 | 190,188,626 | 3.37% | 0.00% |
| Aug. 7, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | S | Common Stock | 1000 | $45.44 | 141,859.0000 | 190,188,626 | 0.70% | 0.00% |
| May 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | F | Common Stock | 4780 | $33.84 | 142,859.0000 | 190,188,626 | 3.24% | 0.00% |
| May 2, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | S | Common Stock | 1026 | $38.51 | 147,639.0000 | 190,188,626 | 0.69% | 0.00% |
| March 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Apuli Maricel | Chief Accounting Officer | A | Common Stock | 23660 | $0.00 | 148,665.0000 | 190,188,626 | 18.93% | 0.01% |